| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |